Support for managing and analyzing complex biological data related to cancer.
Administrative and Biostatistics
This study is all about helping researchers work together better to understand Burkitt lymphoma and its related viruses, which could lead to new treatments that might help patients like you in the future.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wistar Institute NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11085168 on NIH RePORTER |
What this research studies
This research focuses on providing essential administrative and biostatistical support for various projects related to cancer, particularly Burkitt lymphoma and its associated viruses. It aims to facilitate communication and collaboration among researchers by managing data analysis, reporting results, and organizing meetings. The core team will ensure compliance with regulations and provide scientific leadership to enhance the understanding of biological pathways and networks. Patients may benefit indirectly through improved research outcomes and therapies developed from the findings.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit would include individuals affected by Burkitt lymphoma or those at risk due to genetic factors.
Not a fit: Patients with unrelated cancers or conditions not associated with Burkitt lymphoma may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for cancers associated with Burkitt lymphoma and related viruses.
How similar studies have performed: Previous research has shown success in utilizing biostatistical approaches to improve cancer treatment outcomes, indicating a promising avenue for this project.
Where this research is happening
Philadelphia, United States
- Wistar Institute — Philadelphia, United States (Active)
Researchers
- Principal investigator: Lieberman, Paul M. — Wistar Institute
- Study coordinator: Lieberman, Paul M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.